FreeThink recently completed another successful audit of its cGMP analytical facilities and operations, this time requested by a top-50 pharmaceutical company.
Emphasizing good science and advice before starting studies, and with a team of cGMP-trained employees and state-of-the-art, fully qualified instrumentation, FreeThink specializes in cGMP ASAP studies to support market (NDA, aNDA) and post-approval applications. All aspects of these studies are conducted under FreeThink’s robust quality systems, from setups and generation of analytical data using validated methods, to data modeling and the drafting of final reports. The company’s size continues to allow for speed and flexibility, offering fast starts to studies and the quick completion of reports, without compromise.
Contact us to learn more about our cGMP options and to schedule an audit of our facilities and processes.